Hypertensive Heart Disease Severity Scale (HHDS) Calculator

Clinical calculation support · Verify results before clinical use

Cardiac involvement checklist

Select the documented findings. The displayed total is an unvalidated descriptive tally, not a validated severity or prognostic score.

0Points
1. Left ventricular hypertrophy (LVH)

Evidence on ECG or echocardiography, interpreted using the relevant diagnostic criteria.

2. Left atrial enlargement (LAE)

Evidence on cardiac imaging using the applicable measurement and reference range.

3. Diastolic dysfunction

Use the formal echocardiographic assessment; do not infer a grade from symptoms alone.

4. Left ventricular systolic dysfunction

The original template defines this as LVEF <50%. Interpret EF in the full clinical context.

0Points
Descriptive summary

No selected findings

No listed abnormalities are selected. This does not exclude hypertensive-mediated cardiac damage.
Clinical interpretation

This tally has no validated stage boundaries, outcome probabilities, or management thresholds. Assess blood pressure, symptoms, comorbidities, ECG and imaging findings in context.

Maximum tally: 5 points. The point assignments and stage labels in the source code have not been validated as a clinical instrument; the total must not be used to estimate heart-failure risk or determine treatment intensity.

Clinical context and limitations

Hypertension-mediated cardiac organ damage can include left ventricular hypertrophy, left atrial enlargement, impaired left ventricular relaxation/diastolic dysfunction, and eventually systolic dysfunction. These findings are clinically meaningful, but they are not interchangeable and should be established using appropriate ECG and imaging criteria.

Important validation note: the supplied code calls this a “validated” Hypertensive Heart Disease Severity Scale and assigns stages 0–4, but the cited references do not establish or validate this particular four-variable additive score or its stage cutoffs. The calculator therefore retains the source inputs and point tally for transparency while removing unsupported stage and prognostic claims.

Findings represented in this checklist

FindingWhat it representsScoring shown
LVHECG or imaging evidence; ECG alone has limited sensitivity.0 or 1
LAELeft atrial enlargement on imaging.0 or 1
Diastolic dysfunctionFormal assessment and grading using echocardiographic parameters.0, 1, or 2
Systolic dysfunctionSource-code criterion: LVEF <50%.0 or 1

Practical use

  • Use the ECG and echocardiography findings documented in the patient's record.
  • Interpret each abnormality using current standards, relevant sex-specific thresholds where applicable, and the overall clinical presentation.
  • Do not use this unvalidated total as a substitute for formal cardiovascular risk assessment, heart-failure diagnosis, or guideline-directed treatment decisions.

References

McEvoy JW, McCarthy CP, Bruno RM, et al.2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal. 2024;45(38):3912–4018. doi:10.1093/eurheartj/ehae178
Williams B, Mancia G, Spiering W, et al.2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP.Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New England Journal of Medicine. 1990;322:1561–1566. doi:10.1056/NEJM199005313222203
Ganau A, Devereux RB, Roman MJ, et al.Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. Journal of the American College of Cardiology. 1992;19(7):1550–1558. Reference supports patterns of LV remodeling, not validation of this composite score.